Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Bonnet, S. Archer, A. Haromy, E. Michelakis (Edmonton, Canada). A central role for nuclear factor of activated T cells (NFAT) in human pulmonary arterial hypertension. Eur Respir J 2006; 28: Suppl. 50, 991

Member's Comments

No comment yet.

Related content which might interest you: Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension}, Source: Eur Respir J 2012; 40: 895-904 Year: 2012 PDGF promotes pulmonary artery smooth muscle cell proliferation and migration in pulmonary arterial hypertension Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 Inhibition of the Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling Year: 2006 C-kit+ cell recruitment in remodelled pulmonary arteries of human PAH Source: Annual Congress 2007 - Pathogenesis and novel therapeutic targets in pulmonary hypertension Year: 2007 Is pulmonary hypertension associated with a leakage or an activation of endothelial cells? Source: Eur Respir J 2003; 22: Suppl. 45, 74s Year: 2003 Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension Source: Eur Respir J 2007; 29: 462-468 Year: 2007 Inflammation in pulmonary arterial hypertension Source: Eur Respir J 2003; 22: 358-363 Year: 2003 The transcription factor slug is increased in pulmonary artery endothelial cells of COPD patients Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 Increased regulatory T cells in the blood of patients with idiopathic pulmonary arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 659s Year: 2006 Role of c-Abelson in the loss of genome integrity in endothelial cells in pulmonary arterial hypertension Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension Year: 2020 Apoptosis and cell proliferation in chronic hypoxic pulmonary hypertension Source: Lung Science Conference 2007 - Translational research in pulmonary disease: Hypoxia-driven mechanisms Year: 2007 The interleukin 13 receptor system is altered in pulmonary arterial hypertension Source: Annual Congress 2006 - Lung vascular and parenchymal remodeling Year: 2006 Mast cells promote lung vascular remodelling in pulmonary hypertension Source: Eur Respir J 2011; 37: 1400-1410 Year: 2011 Tyrosine kinase inhibition in pulmonary hypertension: the anti-proliferative approach Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 Regulation of inflammation process in chronic thromboembolic pulmonary hypertension: a potential role of platelet-activating factor-acetylhydrolase Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling Year: 2006 IL-6 receptor overexpression in pulmonary arterial smooth muscle cells in idiopathic pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 Effects of C-reactive protein on human pulmonary vascular cells in chronic thromboembolic pulmonary hypertension}, Source: Eur Respir J 2012; 40: 886-894 Year: 2012 Shroom expression is attenuated in pulmonary arterial hypertension Source: Eur Respir J 2008; 32: 871-880 Year: 2008 Stabilised ferroportin activity affects pulmonary vascular cells responses: implications for pulmonary hypertension Source: International Congress 2018 – Experimental research in pulmonary hypertension Year: 2018